glutathione and triple negative breast cancer

glutathione and triple negative breast cancer GSTP1 Is a Driver of Triple-Negative Cell Metabolism Pathogenicity Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for

Name: glutathione and triple negative breast cancer GSTP1 Is a Driver of Triple-Negative Cell Metabolism Pathogenicity Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for
Brand: aimoneimmobiliare.it
SKU: 58106076572
Price: 25.44 USD
Availability: InStock
Rating: 4.2061 (24 reviews)

Glutathione Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor Positive Triple Negative Breast Cancer ACS Nano Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Heterogeneity and transcriptional drivers of triple negative breast cancer: Cell Reports Synthesis of micellar like terpolymer nanoparticles with reductively cleavable cross links and evaluation of efficacy in 2D and 3D models of triple negative breast cancer ScienceDirect GPX4 Inhibitor Resistance and Metastatic Features in TripleNegative Breast Cancer Sabatier 2026 Advanced Science Wiley Online Library

SKU: 58106076572 · From aimoneimmobiliare.it

4.2

USD25.44 USD46.44

Pay in 4 interest-free payments of $6.36 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 8 - Aug 13

Description

The largest increases were observed in Taiwan (Province of China) (EAPC = 3.60, 95% CI: 2.84 to 4.35), Zimbabwe (EAPC = 3.34, 95% CI: 2.52 to 4.16), and Niue (EAPC = 3.04, 95% CI: 2.58 to 3.50), while the most significant declines were recorded in the Grand Duchy of Luxembourg (EAPC = 2.96, 95% CI: 3.07 to 2.85), Tuvalu (EAPC = 2.57, 95% CI: 2.65 to 2.49), and the Republic of Haiti (EAPC = 2.56, 95% CI: 2.74 to 2.38)